为了您的浏览体验,建议您使用Google Chrome浏览本网站。    
    不再提示    
 
 

About Genetron Health

'GENETRON' IS OUR ORIGIN,
OUR SPIRIT, OUR LEGACY.

Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH) is a world-leading precision oncology platform company that specializes in research and application of cancer genomics, providing early screening, medication guidance, prognostic monitoring, and new cancer drug development services that cover the entire spectrum of cancer management. The company is committed to applying innovative genomics technology to cancer-related diagnosis and treatment, and ultimately defeating cancer.

...
CHARLES DARWIN—THE FATHER OF EVOLUTION—PROPOSED THE THEORY OF PANGENESIS, WHICH LAID THE FOUNDATION FOR MODERN GENETICS AND HELPED COIN THE TERM ‘PANGENE’. IN CHINESE, PANGENE IS 泛生子.
..

AN ONCOLOGY PLATFORM
FOR TRANSFORMING CARE

  • EARLY SCREENING
  • DIAGNOSTICS & MONITORING
  • BIOPHARMA SERVICES

THE GENETRON PLATFORM

图片未显示

01

BREAKTHROUGH SCIENCE

At Genetron, we firmly believe in using the best tools that science and technology has to offer for our work, and we hold ourselves to the most rigorous of international standards. From academic research to laboratory operations, precision insights require consistent and thorough processes.

PUBLICATIONS

02

PRECISION SOLUTIONS

Each patient’s journey through cancer is a fiercely personal experience. Whether it’s targeted treatment, continuous monitoring, or actionable guidance, Genetron’s precision solutions are crafted with an emphasis on personalization and participation—for patients and partners alike.

SOLUTIONS
未显示
未显示

03

HUMAN-CENTERED CARE

Breakthrough innovations and the transformations they catalyze are enabled by a zeal for life and empathy for people. Genetron’s core values (B.R.A.V.E.) foster a culture that empowers each of us to navigate ambiguity and discover solutions anchored by the needs of those we serve.

JOIN US

INTERNATIONAL RECOGNITION

profile
money
biulding
group